Labstat Expands into Europe with New Cannabis & Hemp Testing Lab

Labstat, an industry-leading provider of tobacco/nicotine and cannabis/hemp testing and research services, has opened a new laboratory in Utrecht, The Netherlands.

"The opening of our Utrecht laboratory signifies an exciting period of growth for Labstat, presenting us with a unique opportunity to extend our top-notch service to our expanding European client base," said Michael Bond, president of Labstat. "The new facility allows us to provide superior scientific support locally, meaning shorter turnaround times and more streamlined logistics for our customers."

The Utrecht laboratory will commence operations within the next year, focusing on a variety of tobacco/nicotine projects for European customers, offering capacity and readiness to work with clients to scale up testing.

"Whether in North America or Europe, our goal is to deliver the same high-quality Labstat service to all our customers," Bond said. "This network expansion not only amplifies our global footprint but also generates new opportunities for our team to help advance scientific excellence in this industry."

This European expansion aligns with Labstat's objective to have a broader, positive impact on public health by providing globally reliable and comprehensive nicotine, tobacco, cannabis, hemp, and NHP (natural health products) testing and research services.

A Certfied Group company, Labstat's global laboratory network includes operations in Kitchener, Ontario, CAN; Edmonton, Alberta, CAN; Knoxville, TN; and Greensboro, NC.